Clinical trial
Epigenetic Regulation of Altered T-cell Immunity in Sarcoidosis
NCT03145922 is registered in ClinicalTrials.gov with National Jewish Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Epigenetic Regulation of Altered T-cell Immunity in Sarcoidosis
- Lead sponsor
- National Jewish Health
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 31, 2016
- Completion date
- January 31, 2026
- Enrollment
- 45 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.